On April 9, 2020 WHO released their Solidarity Vaccine Trial protocol an ” international randomised trial of candidate vaccines against COVID-19″, those candidates that meet the WHO’s criteria. To coordinate the evaluation of more than 70 vaccines which are currently in development, and 3 in clinical trial as of April 11, 2020.
This WHO vaccine acceleration initiative is headed by Andrew Witty, former CEO of GlaxoSmithKline. [2, 3]
It is unknown what will happen to global vaccine production and supply if the WHO prioritise the same vaccine candidates as the US Warp Speed initiative! [1]